Growth Metrics

Cellectis (CLLS) Inventory (2015 - 2026)

Cellectis (CLLS) posted Inventory of -$26.5 million for Q1 2026, up 71.71% on a QoQ basis from -$93.6 million in Q3 2025, and down 55.48% year-over-year from -$59.5 million in Q1 2025.

Cellectis (CLLS) has 11 years of Inventory data on file, last reported at -$26.5 million in Q1 2026.

  • In Q1 2026, Inventory fell 55.48% year-over-year to -$26.5 million; the TTM figure through Mar 2026 stood at -$26.5 million (down 55.48% YoY), while the FY2020 annual figure was $1.6 million, down 44.77% from the prior year.
  • Inventory grew to -$26.5 million in Q1 2026, from -$93.6 million in the prior quarter.
  • Across five years, Inventory topped out at $23.1 million in Q3 2024 and bottomed at -$93.6 million in Q3 2025.
  • A 4-year average of -$36.6 million and a median of -$28.2 million in 2022 frame the typical range for Inventory.
  • The widest YoY moves for Inventory: up 2.97% in 2022, down 5036.38% in 2022.
  • Year by year, Inventory stood at -$82.6 million in 2022, then soared by 127.93% to $23.1 million in 2024, then sank by 505.58% to -$93.6 million in 2025, then soared by 71.71% to -$26.5 million in 2026.
  • The last three Inventory figures came in at -$26.5 million (Q1 2026), -$93.6 million (Q3 2025), and -$84.3 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 32.00 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 1.77 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 3.10 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 84.03 Mn
10 Cellectis 20.83 Bn 20.62 Bn - -26.48 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -26.48 Mn
Sep 30, 2025 -93.60 Mn
Jun 30, 2025 -84.33 Mn
Mar 31, 2025 -17.03 Mn
Sep 30, 2024 23.08 Mn
Jun 30, 2024 10.79 Mn
Mar 31, 2024 -13.47 Mn
Sep 30, 2022 -82.64 Mn
Jun 30, 2022 -52.41 Mn
Mar 31, 2022 -29.92 Mn
Sep 30, 2021 1.67 Mn
Jun 30, 2021 9.52 Mn
Mar 31, 2021 5.32 Mn
Dec 31, 2020 1.60 Mn
Sep 30, 2020 -83.33 Mn
Jun 30, 2020 -76.55 Mn
Mar 31, 2020 -48.99 Mn
Dec 31, 2019 2.90 Mn
Sep 30, 2019 3.34 Mn
Jun 30, 2019 -53.16 Mn
Mar 31, 2019 1.05 Mn
Dec 31, 2018 275,000.00
Sep 30, 2018 223,000.00
Jun 30, 2018 231,000.00
Mar 31, 2018 203,000.00
Dec 31, 2017 250,000.00
Sep 30, 2017 125,000.00
Jun 30, 2017 -30.03 Bn
Mar 31, 2017 -18.81 Bn
Dec 31, 2016 120,929.11
Sep 30, 2016 -134.54 Bn
Jun 30, 2016 -142.89 Bn
Mar 31, 2016 -123.86 Bn
Mar 31, 2015 -4.35 Mn